These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20298673)

  • 1. p73 and p63 regulate the expression of fibroblast growth factor receptor 3.
    Sayan AE; D'Angelo B; Sayan BS; Tucci P; Cimini A; Cerù MP; Knight RA; Melino G
    Biochem Biophys Res Commun; 2010 Apr; 394(3):824-8. PubMed ID: 20298673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
    Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
    Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 and p73 transcriptionally regulate genes involved in DNA repair.
    Lin YL; Sengupta S; Gurdziel K; Bell GW; Jacks T; Flores ER
    PLoS Genet; 2009 Oct; 5(10):e1000680. PubMed ID: 19816568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells.
    Paull AC; Whikehart DR
    Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
    Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
    Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
    Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
    Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63 and p73 in human cancer: defining the network.
    Deyoung MP; Ellisen LW
    Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of p63 and p73 in human cancers.
    Inoue K; Fry EA
    Subcell Biochem; 2014; 85():17-40. PubMed ID: 25201187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.